Potential for abuse and misuse of pregabalin and gabapentin

Drug and Therapeutics Bulletin

Volumn 55, Issue 3, 2017, Pages 26-

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; OPIATE; PREGABALIN;

CAUSE OF DEATH; DOSE RESPONSE; DRUG ABUSE; DRUG MISUSE; DRUG POTENCY; ENGLAND; EUPHORIA; FINLAND; GERMANY; HUMAN; IRELAND; LEISURE; MOOD CHANGE; NOTE; PRESCRIPTION;

EID: 85019060012     PISSN: 00126543     EISSN: 17555248     Source Type: Journal    
DOI: 10.1136/dtb.2017.3.0459     Document Type: Note

References (6)

1. Advisory Council on the Misuse of Drugs, 2016. Re: pregabalin and gabapentin advice [online]. Available: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/491854/ACMD_Advice:-_Pregabalin_and_gabapentin.pdf [Accessed 15 February 2017].
2. Health and Social Care Board, 2015. Advice for prescribers on the risk of the misuse of pregabalin and gabapentin [online]. Available: http://niformulary.hscni.net/Formulary/Adult/PDF/PregabalinAndGabapentinRiskOfMisuseAdviceHSCBWebVersion.pdf [Accessed 15 February 2017].
3. Public Health England, 2014. Advice for prescribers on the risk of the misuse of pregabalin and gabapentin [online]. Available: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/385791/PHE-NHS_England_pregabalin_and_gabapentin_advice:Dec_2014.pdf [Accessed 15 February 2017].
4. Canadian Agency for Drugs and Technologies in Health, 2012. Abuse and misuse potential of pregabalin: a review of the clinical evidence [online]. Available: https://www.cadth.ca/abuse-and-misuse-potential-pregabalin-review-clinicalevidence [Accessed 15 February 2017].
5. Spence D. Bad medicine: gabapentin and pregabalin. BMJ 2013;347:f6747.
6. Health and Social Care Information Centre, 2016. Prescription Cost Analysis-England, 2015 [online]. Available: http://content.digital.nhs.uk/catalogue/PUB20200 [Accessed 15 February 2016].